24 April 2020 World Gilead Insists Remdesivir May Help, But Study Shows Otherwise The summary of results of a China clinical trial showed remdesivir failed to increase the Covid-19 recovery rate or prevent death from the disease.
20 September 2019 Malaysia Study: Voluntary Licences For Hepatitis C Medicines Boost Treatment Access Voluntary licences can lead to an extra 54 to 69 people annually receiving Hepatitis C treatment per 1,000 individuals diagnosed.
20 May 2019 World AOC Grills Pharma Exec Over Expensive HIV Drug Truvada costs almost US$2,000 in the US, compared to US$8 in Australia.
9 May 2019 World Generic Version of Truvada To Be Available Next Year Gilead has agreed to release its patent.